In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Pharma Commercial Services

Facing a new reality of lower growth, pharmaceutical companies are seeking innovative ways to drive more effective, efficient and responsive commercial operations.

That means focusing more resources on critical commercial decisions and less on gathering, integrating and analyzing data. And it means finding the right partners to help optimize business processes — from data integration and master data management to custom reporting and dashboard generation.

We help pharmaceutical commercial and IT leaders successfully transform their commercial models through distinctive analytic, advisory and implementation services. Our pharmaceutical commercial services draw on our uniquely deep understanding of pharmaceutical commercial analytics and processes, and knowledge of IMS and other leading data sources to help you improve decision-making, lower operating costs and reduce risks. 

IMS focuses on the functions and applications most critical to your commercial success:

Through our flexible engagement model, you can assign to us a single task or an entire business process based on their evolving needs. Learn more about our Business Process Outsourcing capabilities. 

Why IMS

  • Deep-rooted pharma commercial expertise
  • Unparalleled knowledge of IMS and other leading data sources
  • Global scale, covering every major market
  • World-class quality assurance processes
  • More than 3,000 services specialists worldwide
  • Best-of-breed partners, including Oracle, IBM and Netezza

Success Story

Overcoming SPP Data Integration Challenges

How IMS partnered with a client to integrate third-party data and deliver critical specialty channel insights.

Expert Interview

The Benefits of Commercial Analytics for Pharma: A Q&A with IMS's Peter Harbin 

Pete Harbin discusses how pharmaceutical manufacturers can benefit from commercial analytics in this spotlight feature article. 

Analyst Report

Aberdeen Group: The Changing Face of Business Intelligence

Aberdeen

This research brief investigates the performance improvements associated with embedding business intelligence in enterprise applications.

Quality Commitment

iso

Additional Resources